As previously suggested, despite the advantages of modulating GCKR level in improving the regulation of glucose metabolism and reducing the risk of diabetes and kidney disease, its potential adverse side effects such as gout and dyslipidemia need to be taken into account [38]. Here, GCKR is linked to metabolic syndrome.